Observational studyFrontiers in immunology2026

Clinical outcomes and safety of efgartigimod in Guillain-Barré syndrome: a retrospective observation study.

Yongli Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.